gastric bypass vs glp 1 Bariatric Surgery or GLP-1's: Which weight loss treatment is right for you? Metabolic and bariatric surgery versus

Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

National Lipid Association Recommendations for patient-centered management of Dyslipidemia: part 2

The effectiveness of the matching was evaluated using the Standardized Mean Difference (SMD), with an SMD value of less than 0.1 indicating a negligible difference between the groups, thus affirming the efficacy of the matching process

Future outlook Research into GLP-1 patches is progressing quickly, with several pharmaceutical companies reporting positive results from preclinical and early human studies

LeWine, MD, Chief Medical Editor, Harvard Health Publishing